Young adults (aged 18–45 years) have developed increasingly unhealthy risk factors over the past 2 decades, including obesity, poor diet, and physical inactivity
In contrast to older adults, growing evidence in young adults shows that trends in incident cardiovascular disease (especially heart failure) have been increasing or stagnating over the past few decades
Current observations forecast a new epidemic of cardiovascular disease in this young segment of the population as they age
Data on incident cardiovascular disease in young adults are scarce, and estimates are associated with wide confidence intervals owing to the low absolute number of individuals in this population with cardiovascular disease
More data are therefore needed (especially harmonized data between various studies) to establish the epidemiology and trends in overt cardiovascular diseases in young adults
In the past 2 decades, a high prevalence of risk factors for cardiovascular disease, such as obesity, physical inactivity, and poor diet, has been observed among young individuals living in developed countries. The rate of substance abuse (opioids, cocaine, electronic cigarettes, and anabolic steroids) is also increasing among young adults, whereas cigarette smoking might be declining. Among younger individuals (aged 18–50 years), the incidence of cardiovascular diseases over the same time period has either been steady or has increased, in contrast to the trend towards a lower incidence of cardiovascular disease in adults aged >50 years. Current observations might, therefore, be used to forecast a potential epidemic of cardiovascular disease in the near future as the younger segment of the population ages. In this Review, we discuss the burden of risk factors for ischaemic heart disease, heart failure, atrial fibrillation, and sudden cardiac death among young adults aged 18–45 years. Furthermore, we discuss the prevalence, incidence, and temporal trends of various cardiovascular diseases among this young segment of the population.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident cardiovascular disease
BMC Medicine Open Access 10 November 2022
Signal Transduction and Targeted Therapy Open Access 16 September 2022
The link between gestational diabetes and cardiovascular diseases: potential role of extracellular vesicles
Cardiovascular Diabetology Open Access 03 September 2022
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Xanthakis, V. et al. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study. Circulation 130, 1676–1683 (2014).
Spring, B. et al. Healthy lifestyle change and subclinical atherosclerosis in young adults: Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation 130, 10–17 (2014).
Yang, Q. et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 307, 1273–1283 (2012).
Fang, N., Jiang, M. & Fan, Y. Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: a meta-analysis. Int. J. Cardiol. 214, 279–283 (2016).
Nayor, M., Enserro, D. M., Vasan, R. S. & Xanthakis, V. Cardiovascular health status and incidence of heart failure in the Framingham Offspring Study. Circ. Heart Fail. 9, e002416 (2016).
Benjamin, E. J. et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135, e146–e603 (2017).
NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387, 1377–1396 (2016).
Ng, M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 766–781 (2014).
Ogden, C. L., Carroll, M. D., Kit, B. K. & Flegal, K. M. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311, 806–814 (2014).
Rokholm, B., Baker, J. L. & Sorensen, T. I. The levelling off of the obesity epidemic since the year 1999 — a review of evidence and perspectives. Obes. Rev. 11, 835–846 (2010).
Huffman, M. D. et al. Cardiovascular health behavior and health factor changes and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation 125, 2595–2602 (2012).
Hallal, P. C. et al. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 380, 247–257 (2012).
Ng, M. et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA 311, 183–192 (2014).
Page, R. M. & Danielson, M. Multi-country, cross-national comparison of youth tobacco use: findings from global school-based health surveys. Addict. Behav. 36, 470–478 (2011).
World Lung Foundation. Smoking among youth. The Tobacco Atlas http://www.tobaccoatlas.org/topic/smoking-among-youth (2015).
World Health Organization. Tobacco: data and statistics. WHO http://www.euro.who.int/en/health-topics/disease-prevention/tobacco/data-and-statistics(2013).
Filippidis, F. T., Laverty, A. A., Gerovasili, V. & Vardavas, C. I. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob. Control 26, 98–104 (2017).
Benowitz, N. L. & Fraiman, J. B. Cardiovascular effects of electronic cigarettes. Nat. Rev. Cardiol. 14, 447–456 (2017).
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K. & Stein, C. M. Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. JAMA 315, 2415–2423 (2016).
Centers for Disease Control and Prevention. Today's heroin epidemic. CDC https://www.cdc.gov/vitalsigns/heroin/ (2015).
Thiblin, I. et al. Anabolic steroids and cardiovascular risk: a national population-based cohort study. Drug Alcohol Depend. 152, 87–92 (2015).
Lucena, J. et al. Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur. Heart J. 31, 318–329 (2010).
Nilsson, S., Baigi, A., Marklund, B. & Fridlund, B. The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. Eur. J. Publ. Health 11, 195–197 (2001).
McCabe, S. E., Brower, K. J., West, B. T., Nelson, T. F. & Wechsler, H. Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys. Drug Alcohol Depend. 90, 243–251 (2007).
NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 389, 37–55 (2017).
Din-Dzietham, R., Liu, Y., Bielo, M. V. & Shamsa, F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 116, 1488–1496 (2007).
McCarron, P., Smith, G. D. & Okasha, M. Secular changes in blood pressure in childhood, adolescence and young adulthood: systematic review of trends from 1948 to 1998. J. Hum. Hypertens. 16, 677–689 (2002).
Roulet, C. et al. Secular trends in blood pressure in children: a systematic review. J. Clin. Hypertens. (Greenwich) 19, 488–497 (2017).
Niiranen, T. J. et al. Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study. BMJ 357, j1949 (2017).
Andersson, C. et al. Association of parental hypertension with arterial stiffness in nonhypertensive offspring: the Framingham Heart Study. Hypertension 68, 584–589 (2016).
NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387, 1513–1530 (2016).
You, W. P. & Henneberg, M. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Res. Care 4, e000161 (2016).
Imperatore, G. et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 35, 2515–2520 (2012).
Dabelea, D. et al. Association of type 1 diabetes versus type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA 317, 825–835 (2017).
Lavery, J. A., Friedman, A. M., Keyes, K. M., Wright, J. D. & Ananth, C. V. Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010. BJOG 124, 804–813 (2017).
Cho, G. J. et al. Secular trends of gestational diabetes mellitus and changes in its risk factors. PLoS ONE 10, e0136017 (2015).
Zhang, F. et al. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet Med. 28, 652–657 (2011).
Fadl, H. E. & Simmons, D. Trends in diabetes in pregnancy in Sweden 1998–2012. BMJ Open Diabetes Res. Care 4, e000221 (2016).
Ananth, C. V., Keyes, K. M. & Wapner, R. J. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ 347, f6564 (2013).
Auger, N. et al. Secular trends in preeclampsia incidence and outcomes in a large canada database: a longitudinal study over 24 years. Can. J. Cardiol. 32, 987.e15–987.e23 (2016).
Breathett, K., Muhlestein, D., Foraker, R. & Gulati, M. Differences in preeclampsia rates between African American and caucasian women: trends from the National Hospital Discharge Survey. J. Womens Health (Larchmt) 23, 886–893 (2014).
Wallis, A. B., Saftlas, A. F., Hsia, J. & Atrash, H. K. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am. J. Hypertens. 21, 521–526 (2008).
Roberts, C. L. et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open 1, e000101 (2011).
Roberts, C. L., Algert, C. S., Morris, J. M. & Ford, J. B. Increased planned delivery contributes to declining rates of pregnancy hypertension in Australia: a population-based record linkage study. BMJ Open 5, e009313 (2015).
Hwu, L. J. et al. Risk of subsequent hypertension and diabetes in women with hypertension during pregnancy and gestational diabetes. Mayo Clin. Proc. 91, 1158–1165 (2016).
Savitz, D. A., Danilack, V. A., Elston, B. & Lipkind, H. S. Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery. Am. J. Epidemiol. 180, 41–44 (2014).
Farzadfar, F. et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 377, 578–586 (2011).
Ingelsson, E. et al. Contemporary trends in dyslipidemia in the Framingham Heart Study. Arch. Intern. Med. 169, 279–286 (2009).
Carroll, M. D., Kit, B. K., Lacher, D. A., Shero, S. T. & Mussolino, M. E. Trends in lipids and lipoproteins in US adults, 1988–2010. JAMA 308, 1545–1554 (2012).
de Ferranti, S. D. et al. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation 133, 1067–1072 (2016).
Benn, M., Watts, G. F., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J. Clin. Endocrinol. Metab. 97, 3956–3964 (2012).
Nordestgaard, B. G. et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur. Heart J. 34, 3478–3490 (2013).
Shafiq, N., Singh, M., Kaur, S., Khosla, P. & Malhotra, S. Dietary treatment for familial hypercholesterolaemia. Cochrane Database Syst. Rev. 1, CD001918 (2010).
Honors, M. A., Harnack, L. J., Zhou, X. & Steffen, L. M. Trends in fatty acid intake of adults in the Minneapolis-St Paul, MN metropolitan area, 1980–1982 through 2007–2009. J. Am. Heart Assoc. 3, e001023 (2014).
Kit, B. K. et al. Trends in serum lipids among US youths aged 6 to 19 years, 1988–2010. JAMA 308, 591–600 (2012).
Micha, R. et al. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA 317, 912–924 (2017).
Rehm, C. D., Penalvo, J. L., Afshin, A. & Mozaffarian, D. Dietary intake among US adults, 1999–2012. JAMA 315, 2542–2553 (2016).
Gidding, S. S. et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score in young adults predicts coronary artery and abdominal aorta calcium in middle age: the CARDIA study. Circulation 133, 139–146 (2016).
Andersson, C., Enserro, D., Larson, M. G., Xanthakis, V. & Vasan, R. S. Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort. J. Am. Heart Assoc. 4, e001888 (2015).
D'Agostino, R. B. Sr. et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743–753 (2008).
Goff, D. C. Jr. et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 129, S49–S73 (2014).
Gidding, S. S. et al. Prediction of coronary artery calcium in young adults using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score: the CARDIA study. Arch. Intern. Med. 166, 2341–2347 (2006).
Navas-Nacher, E. L., Colangelo, L., Beam, C. & Greenland, P. Risk factors for coronary heart disease in men 18 to 39 years of age. Ann. Intern. Med. 134, 433–439 (2001).
Cole, J. H., Miller, J. I., 3 rd, Sperling, L. S. & Weintraub, W. S. Long-term follow-up of coronary artery disease presenting in young adults. J. Am. Coll. Cardiol. 41, 521–528 (2003).
Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937–952 (2004).
Oliveira, A., Barros, H., Azevedo, A., Bastos, J. & Lopes, C. Impact of risk factors for non-fatal acute myocardial infarction. Eur. J. Epidemiol. 24, 425–432 (2009).
Schoenenberger, A. W. et al. Acute coronary syndromes in young patients: presentation, treatment and outcome. Int. J. Cardiol. 148, 300–304 (2011).
Sharma, M. & Ganguly, N. K. Premature coronary artery disease in Indians and its associated risk factors. Vasc. Health Risk Manag. 1, 217–225 (2005).
Rubin, J. B. & Borden, W. B. Coronary heart disease in young adults. Curr. Atheroscler. Rep. 14, 140–149 (2012).
Khader, Y. S., Rice, J., John, L. & Abueita, O. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception 68, 11–17 (2003).
Afshar, M. et al. Estimating the population impact of Lp(a) lowering on the incidence of myocardial infarction and aortic stenosis-brief report. Arterioscler. Thromb. Vasc. Biol. 36, 2421–2423 (2016).
Nielsen, M. et al. Familial clustering of myocardial infarction in first-degree relatives: a nationwide study. Eur. Heart J. 34, 1198–1203 (2013).
Thanassoulis, G. et al. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ. Cardiovasc. Genet. 5, 113–121 (2012).
Kessler, T., Vilne, B. & Schunkert, H. The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease. EMBO Mol. Med. 8, 688–701 (2016).
Friis-Moller, N. et al. Combination antiretroviral therapy and the risk of myocardial infarction. N. Engl. J. Med. 349, 1993–2003 (2003).
Aggarwal, A., Srivastava, S. & Velmurugan, M. Newer perspectives of coronary artery disease in young. World J. Cardiol. 8, 728–734 (2016).
Incalcaterra, E., Caruso, M., Lo Presti, R. & Caimi, G. Myocardial infarction in young adults: risk factors, clinical characteristics and prognosis according to our experience. Clin. Ter. 164, e77–e82 (2013).
Konishi, H. et al. Long-term prognosis and clinical characteristics of young adults (≤40 years old) who underwent percutaneous coronary intervention. J. Cardiol. 64, 171–174 (2014).
Khera, A. V. et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N. Engl. J. Med. 375, 2349–2358 (2016).
Krarup, N. T. et al. A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals. Atherosclerosis 240, 305–310 (2015).
Christiansen, M. K. et al. A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering. Atherosclerosis 257, 172–178 (2017).
Hindieh, W. et al. Association between family history, a genetic risk score, and severity of coronary artery disease in patients with premature acute coronary syndromes. Arterioscler. Thromb. Vasc. Biol. 36, 1286–1292 (2016).
Carr, J. J. et al. Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death. JAMA Cardiol. 2, 391–399 (2017).
Allen, N. B. et al. Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. JAMA 311, 490–497 (2014).
Okwuosa, T. M., Greenland, P., Ning, H., Liu, K. & Lloyd-Jones, D. M. Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham risk score: the CARDIA study. JACC Cardiovasc. Imag. 5, 923–930 (2012).
Yan, L. L. et al. Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study. JAMA 295, 1793–1800 (2006).
Reis, J. P. et al. Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA 310, 280–288 (2013).
Lee, C. D. et al. Cardiorespiratory fitness and coronary artery calcification in young adults: The CARDIA Study. Atherosclerosis 203, 263–268 (2009).
Hartiala, O. et al. Adolescence risk factors are predictive of coronary artery calcification at middle age: the cardiovascular risk in young Finns study. J. Am. Coll. Cardiol. 60, 1364–1370 (2012).
Schmiegelow, M. D. et al. Prepregnancy obesity and associations with stroke and myocardial infarction in women in the years after childbirth: a nationwide cohort study. Circulation 129, 330–337 (2014).
Andersen, S. S. et al. Impact of metabolic disorders on the relation between overweight/obesity and incident myocardial infarction and ischaemic stroke in fertile women: a nationwide cohort study. Clin. Obes. 5, 127–135 (2015).
Schmidt, M. et al. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open 3, e002698 (2013).
Crump, C., Sundquist, J., Winkleby, M. A. & Sundquist, K. Interactive effects of physical fitness and body mass index on the risk of hypertension. JAMA Intern. Med. 176, 210–216 (2016).
Crump, C., Sundquist, J., Winkleby, M. A. & Sundquist, K. Interactive effects of physical fitness and body mass index on risk of stroke: a national cohort study. Int. J. Stroke 11, 683–694 (2016).
Crump, C., Sundquist, J., Winkleby, M. A. & Sundquist, K. Interactive effects of obesity and physical fitness on risk of ischemic heart disease. Int. J. Obes. (Lond.) 41, 255–261 (2017).
Jin, K. N. et al. Subclinical coronary atherosclerosis in young adults: prevalence, characteristics, predictors with coronary computed tomography angiography. Int. J. Cardiovasc. Imag. 28 (Suppl. 2), 93–100 (2012).
Berenson, G. S. et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N. Engl. J. Med. 338, 1650–1656 (1998).
McManus, D. D. et al. Thirty-year trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. Am. J. Cardiol. 108, 477–482 (2011).
Centers for Disease Control and Prevention. Prevalence of coronary heart disease — United States, 2006–2010. MMWR Morb. Mortal. Wkly Rep. 60, 1377–1381 (2011).
Degano, I. R. et al. Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart 101, 1413–1421 (2015).
Schmidt, M., Jacobsen, J. B., Lash, T. L., Botker, H. E. & Sorensen, H. T. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 344, e356 (2012).
Sulo, G. et al. Favourable trends in incidence of AMI in Norway during 2001–2009 do not include younger adults: a CVDNOR project. Eur. J. Prev. Cardiol. 21, 1358–1364 (2014).
Randall, S. M., Zilkens, R., Duke, J. M. & Boyd, J. H. Western Australia population trends in the incidence of acute myocardial infarction between 1993 and 2012. Int. J. Cardiol. 222, 678–682 (2016).
Gabet, A., Danchin, N., Juilliere, Y. & Olie, V. Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004–2014. Eur. Heart J. 38, 1060–1065 (2017).
Wang, X. et al. Trend in young coronary artery disease in China from 2010 to 2014: a retrospective study of young patients ≤45. BMC Cardiovasc. Disord. 17, 18 (2017).
Kasper, E. K. et al. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J. Am. Coll. Cardiol. 23, 586–590 (1994).
Towbin, J. A. et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296, 1867–1876 (2006).
Wong, C. M. et al. Heart failure in younger patients: the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC). Eur. Heart J. 35, 2714–2721 (2014).
Wong, C. M. et al. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). J. Am. Coll. Cardiol. 62, 1845–1854 (2013).
Barasa, A. et al. Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden. Eur. Heart J. 35, 25–32 (2014).
Christiansen, M. N. et al. Age-specific trends in incidence, mortality and comorbidities of heart failure in Denmark 1995–2012. Circulation 135, 1214–1223 (2017).
Bibbins-Domingo, K. et al. Racial differences in incident heart failure among young adults. N. Engl. J. Med. 360, 1179–1190 (2009).
Damasceno, A. et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch. Intern. Med. 172, 1386–1394 (2012).
Lindgren, M. et al. Cardiorespiratory fitness and muscle strength in late adolescence and long-term risk of early heart failure in Swedish men. Eur. J. Prev. Cardiol. 24 876–884 (2017).
Shah, R. V. et al. Association of fitness in young adulthood with survival and cardiovascular risk: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Intern. Med. 176, 87–95 (2016).
Pandey, A. et al. Fitness in young adulthood and long-term cardiac structure and function: the CARDIA Study. JACC Heart Fail. 5, 347–355 (2017).
Schwartz, B. G., Rezkalla, S. & Kloner, R. A. Cardiovascular effects of cocaine. Circulation 122, 2558–2569 (2010).
Baggish, A. L. et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation 135, 1991–2002 (2017).
Behrens, I. et al. Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy. JAMA 315, 1026–1033 (2016).
Dhesi, S., Savu, A., Ezekowitz, J. A. & Kaul, P. Association between diabetes during pregnancy and peripartum cardiomyopathy: a population-level analysis of 309,825 women. Can. J. Cardiol. 33, 911–917 (2017).
Barasa, A., Rosengren, A., Sandstrom, T. Z., Ladfors, L. & Schaufelberger, M. Heart failure in late pregnancy and postpartum: incidence and long-term mortality in Sweden from 1997 to 2010. J. Card. Fail 23, 370–378 (2017).
Gunderson, E. P. et al. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet. Gynecol. 118, 583–591 (2011).
Sliwa, K. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur. J. Heart Fail 12, 767–778 (2010).
Chen, J., Dharmarajan, K., Wang, Y. & Krumholz, H. M. National trends in heart failure hospital stay rates, 2001 to 2009. J. Am. Coll. Cardiol. 61, 1078–1088 (2013).
Teng, T. H., Finn, J., Hobbs, M. & Hung, J. Heart failure: incidence, case fatality, and hospitalization rates in Western Australia between 1990 and 2005. Circ. Heart Fail 3, 236–243 (2010).
Omersa, D., Farkas, J., Erzen, I. & Lainscak, M. National trends in heart failure hospitalization rates in Slovenia 2004–2012. Eur. J. Heart Fail. 18, 1321–1328 (2016).
Kolte, D. et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J. Am. Heart Assoc. 3, e001056 (2014).
Agarwal, S., Sud, K. & Menon, V. Nationwide hospitalization trends in adult congenital heart disease across 2003–2012. J. Am. Heart Assoc. 5, e002330 (2016).
Christiansen, M. N. et al. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation 135, 1214–1223 (2017).
Benjamin, E. J. et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study. JAMA 271, 840–844 (1994).
Bouchardy, J. et al. Atrial arrhythmias in adults with congenital heart disease. Circulation 120, 1679–1686 (2009).
Pallisgaard, J. L. et al. Risk of atrial fibrillation in diabetes mellitus: a nationwide cohort study. Eur. J. Prev. Cardiol. 23, 621–627 (2016).
Oyen, N. et al. Familial aggregation of lone atrial fibrillation in young persons. J. Am. Coll. Cardiol. 60, 917–921 (2012).
Lubitz, S. A. et al. Genetic risk prediction of atrial fibrillation. Circulation 135, 1311–1320 (2016).
Larsson, S. C., Drca, N. & Wolk, A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J. Am. Coll. Cardiol. 64, 281–289 (2014).
Calvo, N., Brugada, J., Sitges, M. & Mont, L. Atrial fibrillation and atrial flutter in athletes. Br. J. Sports Med. 46 (Suppl. 1), i37–i43 (2012).
Chatterjee, N. A. et al. Genetic obesity and the risk of atrial fibrillation: causal estimates from mendelian randomization. Circulation 135, 741–754 (2016).
Karasoy, D. et al. Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Europace 15, 781–786 (2013).
Schmidt, M., Botker, H. E., Pedersen, L. & Sorensen, H. T. Comparison of the frequency of atrial fibrillation in young obese versus young nonobese men undergoing examination for fitness for military service. Am. J. Cardiol. 113, 822–826 (2014).
Dewland, T. A. et al. Racial differences in left atrial size: results from the coronary artery risk development in young adults (CARDIA) study. PLoS ONE 11, e0151559 (2016).
Dewland, T. A., Olgin, J. E., Vittinghoff, E. & Marcus, G. M. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation 128, 2470–2477 (2013).
Marcus, G. M. et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation 122, 2009–2015 (2010).
Deshmukh, A. et al. Trends in hospitalizations of young patients with atrial fibrillation: a cause for concern? Int. J. Cardiol. 203, 164–165 (2016).
Briffa, T. et al. Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995–2010. Int. J. Cardiol. 208, 19–25 (2016).
Bagnall, R. D. et al. A prospective study of sudden cardiac death among children and young adults. N. Engl. J. Med. 374, 2441–2452 (2016).
Eckart, R. E. et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J. Am. Coll. Cardiol. 58, 1254–1261 (2011).
Arzamendi, D. et al. Increase in sudden death from coronary artery disease in young adults. Am. Heart J. 161, 574–580 (2011).
Christiansen, S. L. et al. Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting. Eur. J. Hum. Genet. 24, 1797–1802 (2016).
Corrado, D., Basso, C., Rizzoli, G., Schiavon, M. & Thiene, G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J. Am. Coll. Cardiol. 42, 1959–1963 (2003).
Feng, J. L. et al. Temporal trends in sudden cardiac death from 1997 to 2010: a data linkage study. Heart Lung Circ. 26, 808–816 (2017).
Moore, M. J. et al. Demographic and temporal trends in out of hospital sudden cardiac death in Belfast. Heart 92, 311–315 (2006).
Ramirez, L. et al. Trends in acute ischemic stroke hospitalizations in the United States. J. Am. Heart Assoc. 5, e003233 (2016).
Demant, M. N. et al. Temporal trends in stroke admissions in Denmark 1997–2009. BMC Neurol. 13, 156 (2013).
Medin, J., Nordlund, A., Ekberg, K. & Swedish Hospital Discharge, R. Increasing stroke incidence in Sweden between 1989 and 2000 among persons aged 30 to 65 years: evidence from the Swedish Hospital Discharge Register. Stroke 35, 1047–1051 (2004).
Bejot, Y. et al. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry. J. Neurol. Neurosurg. Psychiatry 85, 509–513 (2014).
George, M. G., Tong, X. & Bowman, B. A. Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol. 74, 695–703 (2017).
Ford, E. S., Li, C., Zhao, G., Pearson, W. S. & Capewell, S. Trends in the prevalence of low risk factor burden for cardiovascular disease among United States adults. Circulation 120, 1181–1188 (2009).
van Dam, R. M. & Willett, W. C. Unmet potential for cardiovascular disease prevention in the United States. Circulation 120, 1171–1173 (2009).
Koch, M. B., Davidsen, M., Andersen, L. V., Juel, K. & Jensen, G. B. Increasing prevalence despite decreasing incidence of ischaemic heart disease and myocardial infarction. A national register based perspective in Denmark, 1980–2009. Eur. J. Prev. Cardiol. 22, 189–195 (2015).
Egred, M., Viswanathan, G. & Davis, G. K. Myocardial infarction in young adults. Postgrad. Med. J. 81, 741–745 (2005).
Cowie, M. R. et al. Incidence and aetiology of heart failure; a population-based study. Eur. Heart J. 20, 421–428 (1999).
Goyal, A. et al. Predictors of incident heart failure in a large insured population: a one million person-year follow-up study. Circ. Heart Fail. 3, 698–705 (2010).
Zarrinkoub, R. et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur. J. Heart Fail 15, 995–1002 (2013).
Carmona, M. et al. Heart failure in the family practice: a study of the prevalence and co-morbidity. Fam. Pract. 28, 128–133 (2011).
Bongers, F. J., Schellevis, F. G., Bakx, C., van den Bosch, W. J. & van der Zee, J. Treatment of heart failure in Dutch general practice. BMC Fam. Pract. 7, 40 (2006).
Eckart, R. E. et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann. Intern. Med. 141, 829–834 (2004).
This work was supported in part by the Evans Medical Foundation and Jay and Louise Coffman Foundation at the Boston University School of Medicine.
The authors declare no competing financial interests.
About this article
Cite this article
Andersson, C., Vasan, R. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol 15, 230–240 (2018). https://doi.org/10.1038/nrcardio.2017.154
This article is cited by
Nutrition & Metabolism (2022)
Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident cardiovascular disease
BMC Medicine (2022)
Perceived return-to-work pressure following cardiovascular disease is associated with age, sex, and diagnosis: a nationwide combined survey- and register-based cohort study
BMC Public Health (2022)
The link between gestational diabetes and cardiovascular diseases: potential role of extracellular vesicles
Cardiovascular Diabetology (2022)
High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study
Cardiovascular Diabetology (2022)